D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
PUT
DocuSign
DOCU
$13.9B
| $1.15M | ﹤0.01% |
24,200
+6,200
| +34% | +$317K |
2020 Q1
24 quarters
|
|
3252
Expensify
EXFY
$221M
| $1.15M | ﹤0.01% |
1,318,100
-30,650
| -2% | -$36.4K |
2022 Q1
16 quarters
|
|
3253
Southern California Bancorp
BCAL
$702M
| $1.15M | ﹤0.01% |
64,673
-20,056
| -24% | -$367K |
2025 Q4
1 quarter
|
|
3254
Compass Minerals
CMP
$945M
| $1.14M | ﹤0.01% |
49,026
+1,503
| +3% | +$35.4K |
2022 Q4
13 quarters
|
|
3255
PUT
Insperity
NSP
$1.95B
| $1.14M | ﹤0.01% |
+42,300
| New | +$1.36M |
2026 Q1
0 quarters
|
|
3256
PUT
Five Below
FIVE
$12.3B
| $1.14M | ﹤0.01% |
5,000
-33,300
| -87% | -$6.97M |
2021 Q4
17 quarters
|
|
3257
CALL
American Tower
AMT
$85.9B
| $1.14M | ﹤0.01% |
6,600
-9,300
| -58% | -$1.67M |
2013 Q2
51 quarters
|
|
3258
PUT
Sibanye-Stillwater
SBSW
$7.14B
| $1.14M | ﹤0.01% |
+92,300
| New | +$1.44M |
2026 Q1
0 quarters
|
|
3259
Shinhan Financial Group
SHG
$33.1B
| $1.14M | ﹤0.01% |
18,544
-16,428
| -47% | -$1.01M |
2024 Q4
5 quarters
|
|
3260
Cytek Biosciences
CTKB
$686M
| $1.14M | ﹤0.01% |
260,125
-3,001
| -1% | -$14.2K |
2025 Q3
2 quarters
|
|
3261
CALL
Piper Sandler
PIPR
$4.56B
| $1.13M | ﹤0.01% |
14,800
-15,200
| -51% | -$1.25M |
2025 Q2
3 quarters
|
|
3262
ServiceTitan Inc
TTAN
$7.27B
| $1.13M | ﹤0.01% |
17,808
+1,392
| +8% | +$107K |
2025 Q2
3 quarters
|
|
3263
CALL
Vital Farms
VITL
$355M
| $1.13M | ﹤0.01% |
80,000
+21,600
| +37% | +$510K |
2024 Q4
5 quarters
|
|
3264
Metallus
MTUS
$860M
| $1.13M | ﹤0.01% |
68,998
-5,900
| -8% | -$108K |
2014 Q3
46 quarters
|
|
3265
Treace Medical Concepts
TMCI
$258M
| $1.13M | ﹤0.01% |
841,269
+211,139
| +34% | +$421K |
2023 Q1
12 quarters
|
|
3266
Bright Minds Biosciences
DRUG
$512M
| $1.13M | ﹤0.01% |
15,445
+11,528
| +294% | +$928K |
2025 Q4
1 quarter
|
|
3267
Santander
BSBR
$41.6B
| $1.13M | ﹤0.01% |
+189,738
| New | +$1.21M |
2026 Q1
0 quarters
|
|
3268
Orion Office REIT
ONL
$118M
| $1.12M | ﹤0.01% |
521,574
-70,383
| -12% | -$163K |
2023 Q3
10 quarters
|
|
3269
Flagstar Bank National Association
FLG
$4.65B
| $1.12M | ﹤0.01% |
85,145
-157,322
| -65% | -$2.06M |
2025 Q3
2 quarters
|
|
3270
Lindsay Corp
LNN
$1.1B
| $1.12M | ﹤0.01% |
9,415
-2,208
| -19% | -$280K |
2014 Q2
47 quarters
|
|
3271
DELISTED
First Foundation Inc
FFWM
| $1.12M | ﹤0.01% |
189,547
-214,321
| -53% | -$1.3M |
2021 Q4
17 quarters
|
|
3272
Pinduoduo
PDD
$116B
| $1.12M | ﹤0.01% |
+10,940
| New | +$1.15M |
2026 Q1
0 quarters
|
|
3273
PUT
Floor & Decor
FND
$4.92B
| $1.12M | ﹤0.01% |
22,000
-80,400
| -79% | -$5.23M |
2025 Q4
1 quarter
|
|
3274
Algoma Steel
ASTL
$435M
| $1.12M | ﹤0.01% |
270,544
-252,714
| -48% | -$1.1M |
2025 Q3
2 quarters
|
|
3275
iShares MSCI Israel ETF
EIS
$869M
| $1.12M | ﹤0.01% |
9,617
-1,173
| -11% | -$141K |
2025 Q3
2 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.